Company: ANIX
Filing Date: 2025-03-11
Form Type: 10-Q
Source: 0001493152-25-009854
Chunk: 11

Company: Anixa Biosciences Inc
Filing Date: 2025-03-11
Form: 10-Q
Item: Part I, Item 8
Chunk 11
---
 Price

    Number 
Exercisable

    Weighted 
Average 
Remaining 
Contractual Life 
(in years)

    Weighted 
Average 
Exercise Price

    $
    2.09 - $3.87

    6,663,879

    6.5

    $
    3.06

    5,168,886

    5.5

    $
    3.22

    $
    4.02 - $5.30

    5,837,215

    7.4

    $
    4.20

    3,091,663

    7.2

    $
    4.13

Employee Stock Purchase Plan

The Company maintains the Anixa
Biosciences, Inc. Employee Stock Purchase Plan (the “ESPP”) which permits eligible employees to purchase shares at not less
than 85% of the market value of the Company’s common stock on the offering date or the purchase date of the applicable offering
period, whichever is lower. The ESPP was adopted by our Board of Directors on August 13, 2018 and approved by our shareholders on September
27, 2018. During the three months ended January 31, 2025 and 2024, no shares were purchased under the ESPP.

Warrants

As of January 31, 2025, we had
warrants outstanding to purchase 300,000 shares of common stock at $6.56 per share, issued during fiscal year 2021 and expiring on March
22, 2026.

Information regarding the Company’s
warrants for the three months ended January 31, 2025 is as follows:

 SCHEDULE
OF WARRANTS ACTIVITY

    Shares

    Weighted 
Average Exercise 
Price Per Share

    Aggregate 
Intrinsic 
Value

    Warrants outstanding at October 31, 2024

    300,000

    $
    6.56

    Warrants outstanding and exercisable at January 31, 2025

    300,000

    $
    6.56

    $
    0

The following table summarizes
information about the Company’s outstanding and exercisable warrants as of January 31, 2025:

 SCHEDULE OF OUTSTANDING AND EXERCISABLE

    Range of
    Exercise Prices

    Number
    Outstanding and
    Exercisable